iPSCs have the potential to treat a wide range of intractable diseases. In recent years, human embryonic stem cells (hESCs) have gained popularity as a potentially ideal cell candidate for regenerative medicine. hESCs are derived from the inner cell mass of the blastocyte and can be kept in an undifferentiated, self-renewing state indefinitely. In contrast to adult somafic cells, hESCs have the advantage of being pluripotent, which endows them with the ability to differentiate into virtually every cell type in the human body. However, the clinical use of human embryos is controversial in the US, and the problem of tissue rejection following transplantation in patients remains difficult. One way to circumvent these issues is to generate autologous iPSCs. Successful reprogramming of adult fibroblast cells into iPSCs based on defined factors was reported independently in 2008 by Shinya Yamanaka at Kyoto University, Japan {Oct4, Sox2, Klf4, c-Myc) and James Thomson at the University of Wisconsin (Ocf4, Sox2, Nanog, Lin28) (2). The main advantage of iPSCs is that they eliminate the need for human embryos or oocytes to generate patient-specific stem, cells and therefore can potentially bypass the ethical and political debates that have traditionally limited support for this field. A second important advantage is that the use of IPSCs obviates the need for immunosuppressive therapy because the cells are patient-specific. With the rapid progress in the iPSC field, patient-specific and disease-specific iPSCs from individuals with a variety of genetic diseases, such as Duchenne (DMD) and Becker muscular dystrophy (BMD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington disease (HD) have been generated(3,4). Furthermore, different derivatives and cell types have also been generated from IPSCs such as cardiomyocytes and motor neurons (4,5), making iPSCs an attractive candidate for regenerative medicine.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Han, Lin; Zi, Xiaoyuan; Garmire, Lana X et al. (2014) Co-detection and sequencing of genes and transcripts from the same single cells facilitated by a microfluidics platform. Sci Rep 4:6485
Dan, Jiameng; Liu, Yifei; Liu, Na et al. (2014) Rif1 maintains telomere length homeostasis of ESCs by mediating heterochromatin silencing. Dev Cell 29:7-19
Benayoun, Bérénice A; Pollina, Elizabeth A; Ucar, Duygu et al. (2014) H3K4me3 breadth is linked to cell identity and transcriptional consistency. Cell 158:673-88
Tanaka, Yoshiaki; Kim, Kun-Yong; Zhong, Mei et al. (2014) Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2). Hum Mol Genet 23:1045-55
Guo, Shangqin; Zi, Xiaoyuan; Schulz, Vincent P et al. (2014) Nonstochastic reprogramming from a privileged somatic cell state. Cell 156:649-62
Kim, Kun-Yong; Hysolli, Eriona; Tanaka, Yoshiaki et al. (2014) X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Reports 2:896-909
Liu, Na; Liu, Lin; Pan, Xinghua (2014) Single-cell analysis of the transcriptome and its application in the characterization of stem cells and early embryos. Cell Mol Life Sci 71:2707-15
Ebert, Antje D; Kodo, Kazuki; Liang, Ping et al. (2014) Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med 6:255ra130
Buecker, Christa; Srinivasan, Rajini; Wu, Zhixiang et al. (2014) Reorganization of enhancer patterns in transition from naive to primed pluripotency. Cell Stem Cell 14:838-53
Sanchez-Freire, Veronica; Lee, Andrew S; Hu, Shijun et al. (2014) Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol 64:436-48

Showing the most recent 10 out of 24 publications